Partnering with industry

Our goal is to develop effective disease-modifying drugs to treat neurodegenerative diseases. We do so by taking on higher-risk, long-term and less scientifically mature drug discovery projects and bring these projects to a proof-of-concept stage. By offering these opportunities to commercial entities at less cost and lower risk, we link our drug discovery program with the commercial assets of biotechnology and pharmaceutical companies.

Click here to view our business model.